RecruitingNot ApplicableNCT06063928

Confronting Cancer as a Community

Sponsor

University of Southern California

Enrollment

500 participants

Start Date

May 25, 2022

Study Type

INTERVENTIONAL

Conditions

Colorectal Carcinoma

Summary

This study aims to better understand the cause of colorectal cancer and how to find the best treatment for Hispanic patients with colorectal cancer. The genetic information in the blood and tissues may explain why patients who have the same type of cancer and receive the same treatment do not always have the same results. By combining genetic (certain qualities or traits passed from parents to offspring) information with clinical data, such as the responses of different kinds of cancers to different treatments, this study could lead to more knowledge about why certain cancers occur and why they respond differently to treatments. Information gathered from this study may help researchers match treatments to the genetics of each patient and the genetic changes in their tumor. This approach is known as personalized medicine.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is examining colon and rectal cancer in Hispanic communities to better understand how biology (including genetics and the gut microbiome) and cultural and social factors influence cancer risk and outcomes in this population. **You may be eligible if...** - You identify as Hispanic - You have been diagnosed with colon or rectal cancer at any stage, at any time (survivors are welcome) - You are 18 or older - You have a tumor tissue sample stored or are planning to have tissue archived from a standard care procedure - You are willing to consent to the study procedures **You may NOT be eligible if...** - You do not identify as Hispanic - You have not been diagnosed with colon or rectal cancer - You are unwilling to provide tissue or complete study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.